Aganirsen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aganirsen, covering 2016-10-31 to 2016-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG [Phase 2, Phase 3]